Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AVBP | AZN | AMGN | GILD | BMY |
| Company | Arrivent Biopharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 30.09 | 170.70 | 383.25 | 133.11 | 63.65 |
| High | 31.12 | 174.44 | 398.00 | 136.26 | 64.96 |
| Low | 29.30 | 170.67 | 382.21 | 132.63 | 63.20 |
| Latest | 29.98 | 172.48 | 393.10 | 134.32 | 63.60 |
| Change | -0.18 | +2.84 | +16.84 | +3.80 | +1.04 |
| % Change | -0.60% | +1.67% | +4.48% | +2.91% | +1.66% |
| Volume | 818,400 | 4,740,900 | 3,414,400 | 6,947,100 | 15,143,300 |
| 20-Day Average Volume | 545,020 | 2,937,390 | 2,299,955 | 6,646,825 | 10,484,436 |
| Previous Close | 30.16 | 169.64 | 376.26 | 130.52 | 62.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 32.44 | 175.75 | 367.62 | 131.63 | 59.39 |
| 20-Day Raw Stochastic | 31.46% | 26.03% | 88.88% | 61.69% | 84.25% |
| 20-Day Relative Strength | 45.39 | 45.71 | 68.82 | 54.81 | 63.97 |
| Weighted Alpha | +59.58 | +7.13 | +35.28 | +15.51 | +43.07 |
| Today's Opinion | 56% Buy | 88% Sell | 100% Buy | 24% Buy | 72% Buy |
| Previous Opinion | 56% Buy | 88% Sell | 100% Buy | 40% Sell | 72% Buy |
| Last Month's Opinion | 100% Buy | 16% Sell | 56% Buy | 56% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.09% since 07/21/26 | +1.85% since 07/21/26 | +7.33% since 07/21/26 | +3.10% since 07/21/26 | +4.38% since 07/21/26 |
| Low | 27.94 on 07/22/26 | 166.04 on 07/23/26 | 359.21 on 07/23/26 | 127.61 on 07/23/26 | 60.45 on 07/23/26 |
| High | 33.01 on 07/24/26 | 174.44 on 07/28/26 | 398.00 on 07/28/26 | 136.26 on 07/28/26 | 64.96 on 07/28/26 |
| 1-Month | |||||
| %Chg | -11.82% since 06/26/26 | -8.45% since 06/26/26 | +9.70% since 06/26/26 | +5.04% since 06/26/26 | +10.57% since 06/26/26 |
| Low | 27.40 on 07/21/26 | 164.06 on 07/20/26 | 353.95 on 07/15/26 | 124.19 on 06/30/26 | 56.30 on 07/01/26 |
| High | 35.60 on 07/06/26 | 196.41 on 07/02/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 64.96 on 07/28/26 |
| 3-Month | |||||
| %Chg | -0.20% since 04/28/26 | -7.61% since 04/28/26 | +15.76% since 04/28/26 | +3.91% since 04/28/26 | +9.17% since 04/28/26 |
| Low | 25.91 on 05/19/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 35.83 on 06/26/26 | 196.41 on 07/02/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 64.96 on 07/28/26 |
| 6-Month | |||||
| %Chg | +32.83% since 01/28/26 | -7.49% since 01/28/26 | +14.87% since 01/28/26 | -3.86% since 01/28/26 | +16.44% since 01/28/26 |
| Low | 20.00 on 02/11/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 35.83 on 06/26/26 | 212.71 on 02/18/26 | 398.00 on 07/28/26 | 157.29 on 02/11/26 | 64.96 on 07/28/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,404,702 | 263,096,016 | 203,070,544 | 162,049,712 | 127,751,968 |
| Shares Outstanding, K | 46,575 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -166,310,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -43,320,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.29 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.96 on 05/11/26 | 2.63 on 07/27/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/10/26 | 11/05/26 | 08/04/26 | 08/04/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.28 | 17.02 | 15.45 | 10.47 |